Fellow investors, every one of my cell therapy stocks and cancer imunotherapy stock has been capped and shorted non stop.
This assault against new disruptive therapies is real.I believe the sector knows it is under attack and has stuck together.
The positive is that no real stem cell company has sold out and done a cheap partnership.
Meso and other cell therapy companies are so close to completing trials, that a deal has to be made soon.
Time is now working against the big money pharma. They should have made a deal a year or 2 ago.
I believe we are close to the start of our huge stock price rise and more importantly new therapies that actually cure patients.
Good luck fellow dreamers and visionaries.
MSB Trading - 2019, page-1745
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |